Astellas Pharma Lands a First-in-Class Drug Approval in Rare Gastrointestinal Cancer
An Astellas Pharma drug designed to address a novel target has landed a highly anticipated FDA approval for a rare ...
An Astellas Pharma drug designed to address a novel target has landed a highly anticipated FDA approval for a rare ...
Here’s part 2 of MedCity News’ Q&A with Astellas Pharma CEO Naoki Okamura, who was in South San Francisco last ...
Astellas Pharma’s path to winning the first drug approval for a particular promising gastrointestinal cancer target has hit a detour. ...
Copyright © 2024 EuroAsia24 News.
EuroAsia24 News is not responsible for the content of external sites.